S. Potkin

发表

Erratum: Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium (Molecular Psychiatry (2015) DOI:10.1038/mp.2015.63)

I. Melle, O. Andreassen, R. Ophoff, 2016 .

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.

I. Melle, O. Andreassen, R. Ophoff, 2016, Molecular psychiatry.

Are paranoid schizophrenics biologically different from other schizophrenics?

D. Murphy, R. Wyatt, S. Potkin, 1978, The New England journal of medicine.

Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.

R. Poland, S. Potkin, H. Pardes, 1985, Psychopharmacology bulletin.

Topographic Analysis of EEG Photic Driving in Normal and Schizophrenic Subjects

C A Sandman, C. Sandman, J. Bernat, 1995, Clinical EEG.

Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort

S. Potkin, R. Petersen, J. Trojanowski, 2010, Neurology.

Lower CSF level of dynorphin(1–8) immunoreactivity in schizophrenic patients

R. Webber, S. Potkin, J. K. Chang, 1985, Neuropeptides.

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

S. Potkin, A. Tafazzoli, W. Bunney, 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.

S. Akbarian, J. J. Kim, A. Tafazzoli, 1995, Cerebral cortex.

Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains.

E G Jones, W. Bunney, D. Helmeste, 1996, European journal of pharmacology.

Eye movements in remitting and non-remitting schizophrenia.

M. Kharazmi, E. Matsushima, K. Ando, 1986, Clinical neuropharmacology.

Seasonal affective disorder: prevalence varies with latitude and climate.

W. Bunney, D. Kripke, M. Zetin, 1986, Clinical neuropharmacology.

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

I. Melle, O. Andreassen, R. Ophoff, 2016, Molecular Psychiatry.

Explorer Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

I. Melle, Adrian Preda, I. Agartz, 2017 .

Explorer Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

I. Melle, Adrian Preda, I. Agartz, 2016 .